Histochemically determined cell of origin in predicting survival in diffuse huge B-cell lymphoma. Leuk Lymphoma 2012, 53(11):2159165. Koh YW, Kang HJ, Park C, Yoon DH, Kim S, Suh C, Kim JE, Kim CW, Huh J: Prognostic significance of your ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma. Am J Clin Pathol 2012, 138(6):84654. Koh YW, Kang HJ, Park C, Yoon DH, Kim S, Suh C, Go H, Kim JE, Kim CW, Huh J: The ratio on the absolute lymphocyte count to the absolute monocyte count is linked to prognosis in Hodgkin’s lymphoma: correlation with tumor-associated macrophages. Oncologist 2012, 17(six):87180. De Giorgi U, Mego M, Scarpi E, Giuliano M, Giordano A, Reuben JM, Valero V, Ueno NT, Hortobagyi GN, Cristofanilli M: Connection among lymphocytopenia and circulating tumor cells as prognostic components for all round survival in metastatic breast cancer. Clin Breast Cancer 2012, 12(4):26469. Watanabe K, Yamashita Y, Nakayama A, Hasegawa Y, Kojima H, Nagasawa T, Mori N: Varied B-cell immunophenotypes of Hodgkin/reed-Sternberg cells in classic Hodgkin’s illness. Histopathol 2000, 36(four):35361. Carbone A, Gloghini A, Gaidano G, Franceschi S, Capello D, Drexler HG, Falini B, Dalla-Favera R: Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin’s illness. Blood 1998, 92(7):2220228. Buettner M, Greiner A, Avramidou A, Jack HM, Niedobitek G: Evidence of abortive plasma cell differentiation in Hodgkin and reed-Sternberg cells of classical Hodgkin lymphoma. Hematol Oncol 2005, 23(three):12732. Bai M, Panoulas V, Papoudou-Bai A, Horianopoulos N, Kitsoulis P, Stefanaki K, Rontogianni D, Agnantis NJ, Kanavaros P: B-cell differentiation immunophenotypes in classical Hodgkin lymphomas. Leuk Lymphoma 2006, 47(three):49501. Jones RJ, Gocke CD, Kasamon YL, Miller CB, Perkins B, Barber JP, Vala MS, Gerber JM, Gellert LL, Siedner M, et al: Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood 2009, 113(23):5920926. Ibarrola De Andres C, Toscano R, Lahuerta JJ, Martinez-Gonzalez MA: Simultaneous occurrence of Hodgkin’s illness, nodal Langerhans’ cell histiocytosis and numerous myeloma IgA(kappa). Virchows Archiv Int J Pathol 1999, 434(three):25962. Fujii H, Iwai T, Ueda Y, Nakagawa H: [Development of Hodgkin’s illness 4 years immediately after autologous peripheral blood stem cell transplantation for several myeloma].2-Phenylpropionic acid web [Rinsho ketsueki] Japan J Clin Hematol 2000, 41(12):1267272.Anabasine In stock Newcom SR, Gu L: Transforming development aspect beta 1 messenger RNA in reed-Sternberg cells in nodular sclerosing Hodgkin’s illness.PMID:27641997 J Clin Pathol 1995, 48(2):16063. Kuittinen O, Soini Y, Turpeenniemi-Hujanen T: Diverse function of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin’s lymphoma. Eur J Haematol 2002, 69(four):20512.69. Zucker-Franklin D, Grusky G, Baez L: Reed-Sternberg cells cultured from morphologically unidentifiable precursors in the blood of individuals with Hodgkin’s illness. Hematol Oncol 1983, 1(2):12738. 70. Sitar G, Bianchi Santamaria A, Rosti V, Shaskin P, Blago R, Santamaria L, Ascari E: Giant cell formation in Hodgkin’s disease. Res Immunol 1994, 145(7):49915.doi:10.1186/1756-8722-6-62 Cite this article as: Gharbaran et al.: Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are prospective biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma individuals. Journal of Hematology Oncology 2013 six:62.Submit your next manuscript to BioMed Central and take full ad.